Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The Phase 3 TRIUMPH-4 trial (NCT05869903) enrolled adults with obesity and knee osteoarthritis
It does not carry other branded GLP-1 injectables, nor does it offer microdose or drop formats
FDA concerns about unapproved GLP-1 drugs used for weight loss
Close monitoring by a multidisciplinary teamincluding bariatric surgeons, endocrinologists, dietitians, and GPsis essential to ensure safe and effective use
Simplicity matters to many patients, and the single-use pen design requires no dose dialing and comes ready to inject, reducing the chance of dosing errors
US$ 29.29
US$ 24.73
US$ 25.29
US$ 22.65
US$ 25.97
